companies innovating in obesity treatment glp-1 drugs 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers 9 Companies Developing Next-Generation GLP-1

Our team draws on authoritative sources, including systematic reviews published in top-tier medical journals, the latest academic and professional books by renowned experts, and official guidelines from authoritative global health organizations

We help prepare your body for IVF

It is currently unscheduled in the US and included in the World Anti-Doping Agency list of substances banned from use by athletes

Tsuda T, Ueno Y, Yosikawa T, Kojo H, Osawa T

User 15 cited a general dosing range of 2.5 to 3.75mcg per kilogram of body weight twice daily, which, at higher body weights, still produces doses within the standard 250 to 500mcg range being used across the dataset

Studies showed that 91% of people who took tirzepatide (at 15 mg) lost at least 5% of their weight and 57% of people achieved at least a 20% weight reduction after 72 weeks